Skip to content

Optimum Infinite (Tisilfocon A) Orthokeratology Lenses II

by Contamac, Ltd.

PMA P240045

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA P240045↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP240045 Date10 Feb 2026ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
Lens, contact, orthokeratology, overnight
PMA Number
FDA Product Code
NUU
Device Class
Class III
Regulation
21 CFR Part 886.5916
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Optimum Infinite (Tisilfocon A) Orthokeratology Lenses II are contact lenses designed for overnight orthokeratology use. These lenses are classified as Lens, contact, orthokeratology, overnight and are intended to reshape the cornea while worn during sleep, correcting refractive errors during waking hours without daytime lens use. Manufactured from the material tisilfocon A, they are engineered to provide gradual vision correction through overnight wear, targeting myopia management in eligible patients.

These lenses are supplied as single-use or reusable, depending on the specific model and prescription, and are regulated under FDA_PMA with approval number P240045. They fall under device class 3 and are governed by regulation 886.5916, ensuring compliance with stringent ophthalmic standards. Storage and handling must adhere to sterile or clean conditions as specified in the accompanying instructions, with sizes and parameters detailed in the associated product codes (e.g., NUU). No MRI safety information is provided in the specifications.

Other devices from Contamac, Ltd.

See all devices from Contamac, Ltd. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these lenses designed for continuous wear throughout the day, or are they meant to be worn only at night for vision correction?

    These lenses are specifically designed for overnight orthokeratology use only. They reshape the cornea while worn during sleep, allowing patients to achieve clear vision during waking hours without needing to wear contact lenses during the day. This makes them ideal for myopia management in eligible patients.

  • How are the Optimum Infinite (tisilfocon A) Orthokeratology Lenses II supplied, and can they be reused?

    The lenses are supplied as either single-use or reusable, depending on the specific model and prescription. The decision to reuse should follow the manufacturer’s instructions to ensure safety and efficacy, as reuse is not universally applicable across all orthokeratology lenses. Always verify the supply type with the accompanying documentation.

  • What storage and handling conditions are required for these lenses, and how should they be stored to maintain sterility or cleanliness?

    Storage and handling must adhere to sterile or clean conditions as outlined in the manufacturer’s instructions. Since these are medical-grade contact lenses, proper care—such as using approved solutions and avoiding contamination—is critical. The instructions provided with the lenses detail the exact storage requirements to preserve their integrity and safety.

  • What regulatory pathway was followed for approval, and what class does this device fall under?

    The Optimum Infinite (tisilfocon A) Orthokeratology Lenses II were approved under the FDA’s Premarket Approval (PMA) pathway, with approval number P240045. They are classified as Class III devices under regulation 886.5916, indicating they undergo stringent review due to their role in reshaping the cornea for vision correction.

  • Are there different sizes or models available, and how do I determine which one is right for my patient?

    Multiple models exist, each corresponding to specific product codes (e.g., NUU) and prescriptions. The exact sizing and parameters are detailed in the associated product codes listed in the specifications. A certified eye care professional should select the appropriate model based on the patient’s corneal curvature, refractive error, and clinical needs, following the manufacturer’s guidelines.